Library Header Image
LSE Research Online LSE Library Services

Prescribing by general practitioners after an osteoporotic fracture

Torgerson, D. J and Dolan, Paul (1998) Prescribing by general practitioners after an osteoporotic fracture. Annals of the Rheumatic Diseases, 57 (6). pp. 378-379. ISSN 0003-4967

Full text not available from this repository.
Identification Number: 10.1136/ard.57.6.378


OBJECTIVES Osteoporosis is a major cause of morbidity and cost. Patients sustaining one osteoporotic fracture are at increased risk of having another fracture. The objective of this study was to examine the use of “bone drugs” for the prevention of further osteoporotic fractures among patients who have had a “typical” osteoporotic fracture. METHODS This study took a random sample of 300 women aged 50 and over who had sustained either a vertebral, hip or Colles fracture in 1995 from the General Practice Research Database (GPRD) and compared their use of bone drugs with 300 age and practice matched controls. RESULTS Compared with age and practice matched control patients only vertebral fracture patients showed a statistically significant increase in the use of bone drugs in the year after fracture (39% and 2% for cases and controls respectively; 95% CI of difference 27% to 47%). Etidronate was the most commonly used compound. CONCLUSION The majority of patients sustaining an osteoporotic fracture are not prescribed any pharmaceutical agents for the secondary prevention of fracture one year after a primary fracture.

Item Type: Article
Official URL:
Additional Information: © 1998 BMJ Publishing Group Ltd & European League Against Rheumatism
Divisions: Social Policy
Subjects: R Medicine > R Medicine (General)
R Medicine > RD Surgery
Date Deposited: 03 Mar 2011 12:31
Last Modified: 15 May 2024 23:41

Actions (login required)

View Item View Item